【摘要】 采用¹⁵³Sm—EDTMP治疗76例骨转移癌疼痛患者（男57例,女19例;年龄56～82岁）。首次或疗程内用药后疼痛完全缓解27例（35.5％,27/76）,部分缓解43例（56.5％,43/76）,总有效率为92％。影响因素研究表明:76例病人中,年龄、性别、剂量等对止痛效果无明显影响（P>0.05）。¹⁵³Sm—EDTMP对全身各部位的骨转移癌疼痛均有良好的止痛效果,该药对减少临床麻醉剂用量,提高病人生存质量,延长病人寿命均有临床推广和应用价值。更多还原

【Abstract】 Seventy-six patients were treated with single doses of 153Sm-EDTMP for palliation of bone pain from metastatic carcinoma with 92% palliation. No significant differences ( P >0. 05) were found among various age groups,gender and dosage. Responses varied, large lesions responded poorly, small lesions with metastasis and axial skeleton lesions generally responded well.更多还原